Delivery Order SPE2DB22D1017-SPE2DB25FF2QU

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $22,087.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The contract covers the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,479.52, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC, worth up to $999,999,999, serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $3,899.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $9,016.56 Firm Fixed Price Delivery Order is for the supply of the specialty medication COSENTYX SNRDY 300MG DOSE-2PENML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
This federal contract award, valued at $8,390.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,971.50 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $12,857.67, was issued to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The award is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to military healthcare programs globally. The specific items ordered under this delivery order are described as "COSENTYX SNRDY 300MG...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,894.72 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,228.90 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The $10,758.79 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 5, 2024. The contract is a delivery order and does not utilize any set-aside designations. Amerisourcebergen holds a significant $999,999,999 Indefinite...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF2QU
    Delivery Order

This federal contract award, valued at $9,242.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.

The contract covers the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, to support military healthcare programs globally. This award did not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience in providing a comprehensive range of pharmaceutical products and medical supplies to federal agencies, particularly the DLA and the Department of Justice Federal Bureau of Investigation, has enabled the company to secure these critical contracts to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/8/25, 9:47 AM